Drawing for CR CLINICAL RESEARCH CENTER OF THE CAROLINAS

USPTO serial 87079868

CR CLINICAL RESEARCH CENTER OF THE CAROLINAS

Reviewed by CopyMark Law Group

Reg. 5336318Status 710
Filing date
Status date
Registration date
Nov 14, 2017
Examiner
MARTIN, LIEF ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CR CLINICAL RESEARCH CENTER OF THE CAROLINAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffany N. Butler

TIFFANY N. BUTLER BUIST, BYARS & TAYLOR, LLC652 COLEMAN BOULEVARD, SUITE 200MOUNT PLEASANT, SC 29464UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Consulting services in the field of medical product approval for commercial purposes; Business consulting, management, and planning services in the field of product development, device development, cosmeceutical development, drug development, and over the counter ("OTC") product and device development; Business and management consulting for healthcare providers and related businesses; Marketing consultingSECTION 8 - CANCELLEDNov 8, 2016
042Medical research; Product development consultation; Product development for others; Product research and development; Scientific research and development; Pharmaceutical drug development services; Scientific research consulting in the field of product development, device development, cosmeceutical development, drug development, and over the counter ("OTC") product and device development; Technical consulting in the field of pharmaceutical studiesSECTION 8 - CANCELLEDNov 8, 2016
044Consulting services in the field of medical careSECTION 8 - CANCELLEDNov 8, 2016
045Regulatory compliance consulting in the field of prescription drug samplingSECTION 8 - CANCELLEDNov 8, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 28, 2024C8..CANCELLED SEC. 8 (6-YR)—
Nov 14, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 14, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 7, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 6, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 19, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 18, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 18, 2017EX1GSOU EXTENSION 1 GRANTED—
Sep 14, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 23, 2017NREVNOTICE OF REVIVAL - E-MAILED—
Aug 22, 2017IUAFUSE AMENDMENT FILED—
Aug 22, 2017TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Aug 22, 2017PETGPETITION TO REVIVE-GRANTED—
Aug 22, 2017PROATEAS PETITION TO REVIVE RECEIVED—
Aug 22, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 24, 2017EXT1SOU EXTENSION 1 FILED—
Jan 24, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 29, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 29, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 9, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 21, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 18, 2016ALIEASSIGNED TO LIE—
Oct 3, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 29, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Sep 29, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 29, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 29, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 29, 2016DOCKASSIGNED TO EXAMINER—
Jun 29, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jun 28, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 25, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance